Elevate Your Biologics and Biosimilars Innovations with Secerna
Embark on a journey of innovation with Secerna's resolute team, boasting experience in protecting, defending, enforcing and assessing intellectual property (IP) covering High Value Biologics and Biosimilars. From new biologic molecules such as aptamers, peptides and antibodies, to antibody-drug conjugates and delivery vehicles for growth factors and other cargo, our team is well-versed in the dynamic landscape of nucleic acid and protein-based therapeutics. Explore the depth of our capabilities:
Diverse Biologics Protection:
- Experience in protecting, defending, and enforcing IP related to high-value biologics to capture and retain market share.
- Significant capability in post-grant proceedings involving high value biologics including multi-party oppositions.
Protein Manufacturing Landscape Knowledge:
- Considerable knowledge of complex and evolving patent landscapes covering authorized biologics, their therapeutic uses and production.
- Adept understanding of the intricate legal and technological aspects in the High Value Biologics and Biosimilars domain.
Comprehensive Understanding of Protein Manufacturing:
- In-depth understanding of the ever-evolving IP landscape in protein manufacturing, especially relating to monoclonal antibody production.
- Expertise spanning cell culture, upstream and downstream processing, and analytical and quality control techniques.
Elevate Your Biologics and Biosimilars Innovations with Secerna
Partner with Secerna to leverage our specialised knowledge in High Value Biologics and Biosimilars. From diverse biologics protection to navigating the biosimilar landscape and understanding protein manufacturing intricacies, we are committed to propelling your innovations forward.
Please contact us for a complimentary 1-hour consultation to discover how Secerna can tailor its expertise to meet your unique challenges.